GSK was the reason I first bought into OBJ. Agreed Phantom, I...

First 2 Last

Share
Profile

Follow
aussiemika

740 Posts.

13

01/10/14

18:22

Post #: 14059714
Share

Originally posted by Phantom1 ↑

Hi all,

Well today has been interesting to watch. My take is that it is all just meaningless noise from small traders today and the share price is not indicative of where we are at as a company.
Some of you may remember I have been a little frustrated re GSK and the delay in ethics approval. I am no longer concerned due to the annual report clearly saying the process is ongoing, that it is a full blown human clinical trial and they are targeting fluoride and "2 other" advantages (this was new I think - although we knew the fluoride story and we have discussed other potential ingredients).
My take is that if they get the toothbrush to be better than all the rest (dental health or cosmesis) the revenue will be astranomical and ongoing. This, in my view, will be the major company maker and I now think it is going to happen in the not so distant future. This is the announcement I really look forward to.
Just for your consideration, did you know that poor dental hygiene is thought to be one of the major factors in premature births? Try thinking about just this small niche.

cheers all

DYOR please

Expand

GSK was the reason I first
bought into OBJ. Agreed Phantom, I think that's where the big dollars are as well. I'm also excited about the drug delivery technology, and happy to watch the other products roll out whilst we wait for the big ones.

OBJ Price at posting: 9.8¢ Sentiment: Buy Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

RMX

Red Mountain Mining: record gold prices, two projects, two greenstone belts

GDC

Global Data Centres not clear on future operations after AirTrunk sale payout

CBL

Control Bionics expands into UK and Irish markets with NeuroNode device

CNB

Carnaby Resources hits copper at Mohawk, QLD

YAL

Yancoal makes it into the ASX200 in latest S&P rebalance